-+ 0.00%
-+ 0.00%
-+ 0.00%

Aurora-B (06681): Research on multi-cognitive domain digital therapy DELIGHT published in “eClinical Medicine” reveals a new mechanism for “brain-mind treatment”

Zhitongcaijing·11/19/2026 22:25:11
Listen to the news

Zhitong Finance App News, Brain Aurora-B (06681) issued an announcement. The DELIGHT study (a multi-center, double-blind, randomized controlled trial, NCT05704270) carried out jointly with Professor Ma Changsheng's team from Beijing Anzhen Hospital affiliated to Capital Medical University and Professor Wang Jiguang's team from Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was published on November 18, 2026 by the “Willow Leaf Knife” sub-journal and the top international academic journal “eClinical Medicine” (2025 Journal) Impact Factor: 12.8, Q1) was officially released. The study focused for the first time on people with high blood pressure and mild cognitive impairment (MCI), systematically evaluated the intervention effects of 12 weeks of multi-cognitive domain adaptive computerized cognitive training (MD-CCT), and combined with ultra-high field intensity 7T magnetic resonance imaging (MRI) technology, revealed the potential mechanism by which cognitive digital therapy works through the “brain-heart axis”. Cognitive training not only improved patients' cognitive function, but also significantly improved cardiovascular problems such as heart rate in hypertensive patients, that is, “brain training” effectively reduced cardiovascular load. This discovery emphasizes the clinical value of “integrated mind and brain, common prevention and treatment”, provides a new strong evidence-based basis for non-drug intervention for high blood pressure, and also brought good news to the treatment of 270 million hypertensive patients. The research has opened up a major direction for the future industry for the same treatment of mind and brain, and has also opened up broader prospects for cognitive training in the field of cardiovascular disease!

Hypertension and cognitive impairment are the two most common health problems among the elderly. The number of hypertensive patients in China is 270 million. International literature shows that the incidence of cognitive impairment in hypertensive patients is 30-50%. Long-term high blood pressure damages blood vessels and causes cognitive function to decline; impaired cognitive function also reduces patients' quality of life and adherence to antihypertensive treatment. Among the elderly aged 65 and over, the prevalence of high blood pressure is over 75%, and the risk of developing middle to advanced dementia in hypertensive patients is increased by about 70%. Previous studies have focused more on the one-way approach of “controlling blood pressure to protect the brain,” yet there is no high-quality evidence that cognitive intervention targeting the brain can in turn improve cardiovascular health.

The DELIGHT study was jointly conducted by 11 hospitals in China. A total of 217 patients with hypertension and MCI were recruited and randomly divided into 2 groups according to 1:1

Intervention group (n=108): Received 12 weeks of multi-cognitive domain adaptive CCT (MD-CCT) to conduct comprehensive training on multiple cognitive functional areas; after completing the first 12 weeks of training, they were randomly distributed again, and decided to continue training or stop training for the next 12 weeks to observe the durability of the results.

Positive control group (n=109): Received CCT (FD-CCT) targeting only the two basic cognitive domains of perception and attention.

Both groups of patients carried out training using the “Brain Function Information Management Platform Software System” (Class II medical device, according to Hunan Device: 20182210142) developed by the Group. The study performed standardized cognitive scale assessments and standardized blood pressure and pulse pressure measurements during baseline, 12 weeks, and 24 weeks of follow-up; 32 of these patients underwent multi-modal MRI scans (including resting functional magnetic resonance and structural imaging) before and after training, focusing on tracking functional connectivity and changes in gray matter density between the ventral attention network (VAN) and executive control network (ECN).

Core research findings:

Improvement of brain microstructure: The functional connections of neural networks responsible for attention, executive control, and contextual memory in the patient's brain are significantly enhanced; gray matter density in the hippocampus, which is the core hub of memory, has increased significantly, suggesting that cognitive training not only activates brain function, but also improves brain tissue structure to a certain extent.

Cross-system benefits: Compared with the control group, patients receiving MD-CCT training not only improved cognitive function, but cardiovascular indicators were also significantly optimized, showing lower diastolic pressure, a more stable heart rate, and a significant decrease in heart rate and blood pressure product (RPP, a core index reflecting cardiac oxygen consumption and workload), suggesting that systemic cognitive intervention can “reduce the burden” on the heart.

“Brain-heart axis” mechanism: Analysis of mediating effects shows that improved brain neural network connectivity is a key bridge between “cognition” and “heart”; increased functional connectivity is significantly negatively correlated with decreased heart rate, that is, the more efficient the brain network connection, the more obvious the drop in heart rate and the more stable the beating.

24-week long-term follow-up: The 24-week follow-up showed that regardless of whether patients continued training for the next 12 weeks (MD-keep group) or stopped training (MD-stop group), the reduction in diastolic pressure was significantly superior to that of the FD-CCT control group, suggesting that 12 weeks of high-quality cognitive training had a long-lasting protective effect on the cardiovascular system.

This study provides a new perspective on the treatment of hypertension combined with cognitive impairment. That is, “brain training” effectively reduces cardiovascular load and brings good news to hypertensive patients. It also means that the company's products have opened up a broad new market space for long-term treatment of these patients. Based on existing evidence, multi-dimensional digital cognitive training is not only a rehabilitation method for the brain, but also a new non-drug intervention strategy that can simultaneously stimulate neuroplasticity and improve cardiovascular function. This intervention model can effectively complement vascular risk management such as traditional antihypertensive drugs; at the same time, digital therapy has high safety, no risk of drug interaction, and can break the physical time and space limitations of traditional rehabilitation, enable patients to receive standardized intervention in the community or at home, and improve treatment accessibility.

The group's research team, led by CEO Cai Longjun, participated deeply in this study. The board of directors believes that the above results reflect the Group's leading capabilities in cognitive digital therapy and real-world research and clinical transformation of “brain-heart comorbidities”, further expand the Group's evidence-based digital therapy landscape, are in line with the Group's long-term development strategy, help consolidate the Group's leading position in the field of digital therapy for cognitive impairment, and create long-term value for shareholders.